股權變動
日期 代號 名稱 股東名稱 披露
原因
買入/賣出涉及
的股份數目
每股平均價 持有權益的
股份數目
佔已發行
股本(%)
14/08/202502359藥明康德BlackRock, Inc.1314(L)281,000(L)26,602,903(L)
277,464(S)
5.73
0.06
14/08/202503999大成食品韋俊賢1101(L)+69,000(L)HKD 0.630(L)331,000(L)0.03
14/08/202506955博安生物Luye Pharma Group Ltd.1213(L)
1213(S)
360,596,456(L)
74,387,153(S)
57.94
11.95
14/08/202502350數科集團QH Technology Holdings Limited1710(L)3,360,000(L)362,115,000(L)57.94
14/08/202502350數科集團刘霞1710(L)3,360,000(L)362,115,000(L)57.94
14/08/202500952華富建業金融韓曉生1201(L)-540,000(L)HKD 0.160(L)4,189,259,571(L)67.60
14/08/202506682第四範式富国基金管理有限公司1213(L)18,467,800(L)5.76
14/08/202500434博雅互動陶穎1316(L)6,666(L)400,000(L)0.06
14/08/202501772贛鋒鋰業JPMorgan Chase & Co.1314(L)+988,000(L)32,615,638(L)
20,052,269(S)
4,052,530(P)
8.08
4.96
1.00
14/08/202500772閱文集團侯曉楠1316(L)250,000(L)5,188,674(L)0.51
14/08/202502359藥明康德FMR LLC1314(L)1,977,754(L)54,365,883(L)11.71
14/08/202500522ASMPTCitigroup Inc.1113(L)
1403(S)
+3,170,791(L)
+3,866,588(S)
HKD 0.000(L)29,300,661(L)
5,570,657(S)
23,437,718(P)
7.03
1.33
5.62
14/08/202509626嗶哩嗶哩-WBlackRock, Inc.1004(L)+1,449,073(L)17,926,096(L)
15,367(S)
5.28
0.00
14/08/202506682第四範式Paradigm (Tianjin) Management Consulting Partnership (Limited Partnership)1213(L)25,443,667(L)7.93
14/08/202500187京城機電股份The Bank of New York Mellon Corporation1004(L)+1,916,000(L)5,989,364(L)5.99
14/08/202509688再鼎醫藥FMR LLC1316(L)34,000(L)93,668,827(L)8.38
14/08/202503759康龍化成JPMorgan Chase & Co.1704(L)-1,079,550(L)HKD 22.557(L)14,187,988(L)
7,197,204(S)
2,728,148(P)
4.70
2.38
0.90
14/08/202501405達勢股份JPMorgan Chase & Co.16022(L)-235,720(L)HKD 83.994(L)7,678,545(L)
192,600(S)
7,448,445(P)
5.86
0.14
5.68
14/08/202500950李氏大藥廠Li Zhenfu1201(L)-3,397,000(L)HKD 1.944(L)63,770,488(L)10.83
14/08/202506955博安生物刘殿波1213(L)
1213(S)
360,596,456(L)
74,387,153(S)
57.94
11.95
14/08/202502350數科集團QH Technology Holdings Limited1101(L)+3,360,000(L)362,115,000(L)57.94
14/08/202506682第四範式Beijing New Wisdom Pilot Management Consulting Co., Ltd.1213(L)28,968,692(L)9.03
14/08/202500950李氏大藥廠GL Partners Capital Management Ltd.1201(L)-3,397,000(L)HKD 1.944(L)63,770,488(L)10.83
14/08/202502318中國平安BlackRock, Inc.1313(L)629,147(L)434,728,700(L)
8,591,500(S)
5.84
0.12
14/08/202502186綠葉製藥LuYe Pharmaceutical Investment Co., Ltd.1213(L)
1213(S)
1,246,108,703(L)
212,229,950(S)
32.49
5.53
14/08/202502359藥明康德Citigroup Inc.1704(L)
1502(S)
-6,172,853(L)
-1,339,921(S)
HKD 0.000(L)22,471,232(L)
4,459,999(S)
15,348,029(P)
4.84
0.96
3.30
14/08/202501276恒瑞醫藥JPMorgan Chase & Co.1101(L)+291,082(L)HKD 78.851(L)28,577,650(L)
5,536,395(S)
11,244,862(P)
11.06
2.14
4.35
14/08/202501276恒瑞醫藥JPMorgan Chase & Co.1314(L)+203,599(L)28,577,650(L)
5,536,395(S)
11,244,862(P)
11.06
2.14
4.35
14/08/202509939開拓藥業-BTong Youzhi1111(L)+20,673,000(L)50,050,270(L)10.69
14/08/202501929周大福UBS Group AG10031(L)+52,540,416(L)513,737,825(L)
474,049,104(S)
5.21
4.81
14/08/202501088中國神華BlackRock, Inc.1313(L)599,000(L)176,404,879(L)
395,000(S)
5.22
0.01
14/08/202501709德林控股陳寧迪1711(L)817,592,661(L)46.70
14/08/202506178光大證券易方达基金管理有限公司1101(L)+258,600(L)HKD 11.224(L)49,498,200(L)7.03
14/08/202502359藥明康德BlackRock, Inc.1205(L)-5,409,309(L)26,602,903(L)
277,464(S)
5.73
0.06
14/08/202506099招商證券易方达基金管理有限公司1101(L)+468,000(L)HKD 17.512(L)89,653,440(L)7.03
14/08/202506196鄭州銀行弘康人寿保险股份有限公司1101(L)+28,249,000(L)HKD 1.429(L)399,516,000(L)19.77
14/08/202501456國聯民生易方达基金管理有限公司1101(L)+232,000(L)HKD 6.628(L)44,454,000(L)10.04
14/08/202500182協合新能源Splendor Power Limited1101(L)+2,000,000(L)HKD 0.415(L)766,827,087(L)9.73
14/08/202506955博安生物AsiaPharm Investments Ltd.1213(L)
1213(S)
360,596,456(L)
74,387,153(S)
57.94
11.95
14/08/202501375中州證券易方达基金管理有限公司1101(L)+627,000(L)HKD 2.777(L)120,050,000(L)10.04
  1    2    3    4    5    6    7   8    9    10  
備註: (L) - 長倉:包括 (1) 持有股份;(2) 透過持有、沽出或發行金融合約,有權或有責任購買相關股份。
  (S) - 短倉:包括 (1) 借入股份;(2) 透過持有、沽出或發行金融合約,有權或有責任沽出相關股份。
  (P) - 可供借出的股份
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.